Page 314 - IJB-9-1

International Journal of Bioprinting Error assessment and correction

to an acceptable range. This method showed a significant References
reduction effect for high error areas. More importantly, the
error of the correction results was in a normal distribution 1. Hart A, Smith JM, Skeans MA, et al., 2020, OPTN/SRTR
instead of a random distribution, thus proving that this 2018 annual data report: Kidney. Am J Transplant, 20(s1):
method based on computer vision is universal for different 20–130.
locations. https://doi.org/10.1111/ajt.15672
This research has demonstrated a method for 2. Abouna GM, 2008, Organ shortage crisis: Problems and
effectively detecting defects and correcting errors in the possible solutions. Transplant Proc, 40(1): 34–38.
field of bioprinting. In fact, this method is also suitable https://doi.org/10.1016/j.transproceed.2007.11.067
for improving the resolution of printing other organs. We
hope that bioprinting can further advance and create new 3. Croome KP, Lee DD, Keaveny AP, et al., 2017, Noneligible
opportunities for regenerative medicine. donors as a strategy to decrease the organ shortage. Am J
Transplant, 17(6): 1649–1655.
Acknowledgments https://doi.org/10.1111/ajt.14163
This researchers thank the National Natural Science 4. Bastani B, 2020, The present and future of transplant organ
shortage: Some potential remedies. J Nephrol, 33(2): 277–288.
Foundation of China, Shanghai Science and Technology
Commission, Guangxi Science and Technology Program, https://doi.org/10.1007/s40620-019-00634-x
and Guangxi Key R&D Project. 5. Vijayavenkataraman S, Yan WC, Lu WF, et al., 2018, 3D
bioprinting of tissues and organs for regenerative medicine.
Funding Adv Drug Deliv Rev, 132: 296–332.
National Natural Science Foundation of China (Grant https://doi.org/10.1016/j.addr.2018.07.004
Nos.: 51831011, 52011530181), Shanghai Science and 6. Pedde RD, Mirani B, Navaei A, et al., 2017, Emerging
Technology Commission (Grant No.: 20S31900100), biofabrication strategies for engineering complex tissue
Guangxi Science and Technology Program (Guike Jizi constructs. Adv Mater, 29(19): 1–27.
[2020] No. 198), and Guangxi Key R&D Project (Guike https://doi.org/10.1002/adma.201606061
AB18050008).
7. van Pel DM, Harada K, Song D, et al., 2018, Modelling
Author contributions glioma invasion using 3D bioprinting and scaffold-free 3D
culture. J Cell Commun Signal, 12(4): 723–730.
Conceptualization: Changxi Liu, Liqiang Wang https://doi.org/10.1007/s12079-018-0469-z
Data curation: Changxi Liu, Chengliang Yang, Jia Liu
Funding acquisition: Yujin Tang, Zhengjie Lin, Long Li, 8. Liu C, Yang C, Liu J, et al., 2022, Medical high-entropy
Hai Liang alloy: Outstanding mechanical properties and superb
Methodology: Changxi Liu, Weijie Lu biological compatibility. Frontiers in Bioengineering and
Writing – original draft: Changxi Liu, Jia Liu, Yujin Tang, Biotechnology, 1436.
Hai Liang, Weijie Lu, Liqiang Wang https://doi.org/10.3389/fbioe.2022.952536
Writing – review & editing: Changxi Liu, Jia Liu, Yujin 9. Yu F, Choudhury D, 2019, Microfluidic bioprinting for organ-
Tang, Hai Liang, Weijie Lu, Liqiang Wang on-a-chip models. Drug Discov Today, 24(6): 1248–1257.
https://doi.org/10.1016/j.drudis.2019.03.025
Ethics approval and consent to participate
10. Li S, Tian X, Fan J, et al., 2019, Chitosans for tissue repair and
Not applicable. organ three-dimensional (3D) bioprinting. Micromachines,
10(11): 765.
Consent for publication
https://doi.org/10.3390/mi10110765
Not applicable.
11. Tseng H, Gage JA, Shen T, et al., 2015, A spheroid toxicity
assay using magnetic 3D bioprinting and real-time mobile
Availability of data device-based imaging. Sci Rep, 5: 1–11.
Experimental data are measured and analyzed by computer. https://doi.org/10.1038/srep13987

V
Volume 9 Issue 1 (2023)olume 9 Issue 1 (2023) 306 https://doi.org/10.18063/ijb.v9i1.644